Zurcher Kantonalbank (Zurich Cantonalbank) Myriad Genetics Inc Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$33.8 Billion
Q1 2025

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Myriad Genetics Inc stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 27,560 shares of MYGN stock, worth $143,036. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,560

Previous 27,179 1.4%

Holding current value

$143,036

Previous $372,000 34.41%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 07, 2025	BUY	$8.87 - $14.98 $3,379 - $5,707	381 Added 1.4%	27,560 $244,000
Q4 2024 Feb 07, 2025	BUY	$13.17 - $27.03 $70,499 - $144,691	5,353 Added 24.53%	27,179 $372,000
Q2 2024 Jul 29, 2024	BUY	$17.98 - $25.47 $4,746 - $6,724	264 Added 1.22%	21,826 $533,000
Q1 2024 Apr 25, 2024	BUY	$17.59 - $23.59 $22,110 - $29,652	1,257 Added 6.19%	21,562 $459,000
Q4 2023 Jan 30, 2024	BUY	$13.91 - $21.32 $88,564 - $135,744	6,367 Added 45.68%	20,305 $388,000
Q2 2023 Aug 07, 2023	BUY	$17.56 - $23.76 $4,021 - $5,441	229 Added 1.67%	13,938 $323,000
Q1 2023 May 08, 2023	BUY	$15.26 - $23.75 $42,499 - $66,143	2,785 Added 25.49%	13,709 $318,000
Q4 2022 Feb 01, 2023	BUY	$14.51 - $20.99 $1,131 - $1,637	78 Added 0.72%	10,924 $158,000
Q1 2022 Apr 21, 2022	SELL	$22.67 - $28.01 $57,853 - $71,481	-2,552 Reduced 19.05%	10,846 $273,000
Q4 2021 Feb 01, 2022	BUY	$24.13 - $32.63 $40,104 - $54,231	1,662 Added 14.16%	13,398 $370,000
Q3 2021 Nov 15, 2021	BUY	$29.97 - $36.66 $2,457 - $3,006	82 Added 0.7%	11,736 $379,000
Q2 2021 Jul 30, 2021	BUY	$25.39 - $32.61 $3,579 - $4,598	141 Added 1.22%	11,654 $356,000
Q1 2021 May 03, 2021	BUY	$19.92 - $31.6 $52,509 - $83,297	2,636 Added 29.69%	11,513 $351,000
Q4 2020 Jan 28, 2021	BUY	$12.16 - $19.77 $27,311 - $44,403	2,246 Added 33.87%	8,877 $176,000
Q2 2020 Jul 28, 2020	BUY	$10.69 - $16.49 $14,174 - $21,865	1,326 Added 25.0%	6,631 $75,000
Q1 2020 May 06, 2020	BUY	$9.78 - $29.53 $8,254 - $24,923	844 Added 18.92%	5,305 $76,000
Q2 2019 Jul 30, 2019	BUY	$22.67 - $35.0 $10,586 - $16,345	467 Added 11.69%	4,461 $124,000
Q1 2019 Apr 29, 2019	SELL	$26.93 - $34.7 $30,780 - $39,662	-1,143 Reduced 22.25%	3,994 $133,000
Q4 2018 Jan 25, 2019	BUY	$27.23 - $45.56 $17,971 - $30,069	660 Added 14.74%	5,137 $149,000
Q2 2018 Aug 06, 2018	BUY	$27.75 - $40.17 $24,780 - $35,871	893 Added 24.92%	4,477 $167,000
Q4 2017 Jan 31, 2018	BUY	$28.45 - $37.14 $10,355 - $13,518	364 Added 11.3%	3,584 $123,000
Q3 2017 Nov 08, 2017	BUY	$24.01 - $36.2 $77,312 - $116,564	3,220	3,220 $116,000

Others Institutions Holding MYGN

# of Institutions

240

Shares Held

95.3M

Call Options Held

95.4K

Put Options Held

18.2K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $418M
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Myriad Genetics Inc Transaction History